Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Atea Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 105 | 1 | 108 | +4 |
| Shares | 56.7M | 9.12M | 57.9M | +10.3M (+21.7%) |
| Value | $187.7M | $30.2M | $194.0M | +$36.5M (+23.2%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 8,990,734 | $30.1M | 0.00% |
| Woodline Partners LP | 103,358 | $346.2K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 44,157 | $147.9K | 0.00% |
| Virtu Financial LLC | 29,491 | $99.0K | 0.01% |
| Zacks Investment Management | 23,940 | $80.2K | 0.00% |
| Ieq Capital, LLC | 13,964 | $46.8K | 0.00% |
| Brevan Howard Capital Management LP | 13,868 | $46.5K | 0.00% |
| AQR Capital Management LLC | 13,143 | $44.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 11,178 | $37.0K | 0.00% |
| Oxford Asset Management LLP | 10,912 | $36.6K | 0.03% |
| Intech Investment Management LLC | 10,711 | $35.9K | 0.00% |
| Global Retirement Partners, LLC | 1,389 | $4.65K | 0.00% |
| Meeder Asset Management Inc | 1,281 | $4.29K | 0.00% |
| Sterling Capital Management LLC | 245 | $821 | 0.00% |
| Capital Performance Advisors LLP | 31 | $104 | 0.00% |
Sold out (11)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Marshall Wace, LLP | 182,326 | $603.5K |
| Cubist Systematic Strategies, LLC | 34,045 | $112.7K |
| Toroso Investments, LLC | 18,419 | $61.0K |
| Principal Financial Group Inc | 11,425 | $37.8K |
| Qube Research & Technologies Ltd | 8,235 | $27.3K |
| Redwood Wealth Management Group, LLC | 5,000 | $16.6K |
| Rothschild Investment LLC | 3,150 | $10.4K |
| Point72 Asia (Singapore) Pte. Ltd. | 3,028 | $10.0K |
| Frazier Financial Advisors, LLC | 120 | $398 |
| Smartleaf Asset Management LLC | 46 | $155 |
| Colonial Trust Advisors | 46 | $152 |
Not filed for Q3 2024 yet (1)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 9,120,563 | $30.2M |